Pharmaceutical Economics and Policy
Most cited papers
- EQ-SD: a measure of health status from the EuroQol GroupAnnals of Medicine · 2001 · 5,739 citations
- Bad Bugs, No Drugs: No ESKAPE! An Update from the Infectious Diseases Society of AmericaClinical Infectious Diseases · 2008 · 5,099 citations
- Recommendations for Conduct, Methodological Practices, and Reporting of Cost-effectiveness AnalysesJAMA · 2016 · 3,153 citations
- Can Patents Deter Innovation? The Anticommons in Biomedical ResearchScience · 1998 · 2,700 citations
- Recommendations of the Panel on Cost-Effectiveness in Health and MedicineJAMA · 1996 · 2,510 citations
- Pharmaceutical industry sponsorship and research outcome and quality: systematic reviewBMJ · 2003 · 2,157 citations
- Foundations of Cost-Effectiveness Analysis for Health and Medical PracticesNew England Journal of Medicine · 1977 · 2,139 citations
- Data Resource Profile: The Danish National Prescription RegistryInternational Journal of Epidemiology · 2016 · 1,468 citations
- The Promotion and Marketing of OxyContin: Commercial Triumph, Public Health TragedyAmerican Journal of Public Health · 2008 · 976 citations
Metadata from OpenAlex (CC0).